(NASDAQ: MIRA) Mira Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 106.09%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 52.93%.
Mira Pharmaceuticals's earnings in 2025 is -$7,918,667.On average, 1 Wall Street analyst forecast MIRA's earnings for 2025 to be -$7,444,634, with the lowest MIRA earnings forecast at -$7,444,634, and the highest MIRA earnings forecast at -$7,444,634.
In 2026, MIRA is forecast to generate -$6,937,045 in earnings, with the lowest earnings forecast at -$6,937,045 and the highest earnings forecast at -$6,937,045.